Metabolic Checkpoints: Targeting Immunometabolism as a Novel Therapeutic Strategy in Neurologic Diseases
Neuropharmacology and Therapy · 2026 · 3
DOI: 10.15212/npt-2025-0024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropharmacology and Therapy, 2026. Verfasst von Qicheng Guan und 4 weiteren Autor:innen. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunity and metabolism have been considered two relatively independent systems for decades. In recent years these two systems have been shown to interact with each other and jointly maintain homeostasis. This review integrates multidisciplinary approaches in the field of neuroimmunometabolism research, encompassing metabolic flux analysis, in vivo imaging, and multi-omics integration, while assessing applicability and constraints in decoding cellular metabolic states. Therapeutic targets are discussed across metabolic pathways (glycolysis, mitochondrial metabolism, amino acid metabolism, and lipid metabolism). The review further establishes connections between neurologic disorders and metabolic targets, thereby introducing immunometabolism as a pivotal regulator of immune cell function in the CNS. These new findings provide deeper insights into metabolic reprogramming, paving the way for future targeted therapies by targeting metabolic pathways in the treatment of neuroinflammation and neurologic disorders.
Zitieren
APA
Guan, Q., Wang, B., Hou, J., Hu, R., & Li, W. (2026). Metabolic Checkpoints: Targeting Immunometabolism as a Novel Therapeutic Strategy in Neurologic Diseases. Neuropharmacology and Therapy, 3. https://doi.org/10.15212/npt-2025-0024
Vancouver
Guan Q, Wang B, Hou J, Hu R, Li W. Metabolic Checkpoints: Targeting Immunometabolism as a Novel Therapeutic Strategy in Neurologic Diseases. Neuropharmacology and Therapy. 2026;3. doi:10.15212/npt-2025-0024
BibTeX
@article{Guan2026,
author = {Guan, Qicheng and Wang, Bo and Hou, Jingming and Hu, Rong and Li, Wenyan},
title = {Metabolic Checkpoints: Targeting Immunometabolism as a Novel Therapeutic Strategy in Neurologic Diseases},
journal = {Neuropharmacology and Therapy},
year = {2026},
volume = {3},
doi = {10.15212/npt-2025-0024}
}
EUVIMED